Skip to main content
. 2020 Jul 16;2020(7):CD008037. doi: 10.1002/14651858.CD008037.pub4

Comparison 2. Chronic infection: garlic supplementation versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Respiratory function (% change FEV1) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1.1 Over 1 month and up to 3 months 1 26 Mean Difference (IV, Fixed, 95% CI) 1.59 [‐7.49, 10.67]
2.2 Mortality 1   Odds Ratio (M‐H, Fixed, 95% CI) Totals not selected
2.2.1 Over 1 month and up to 3 months 1   Odds Ratio (M‐H, Fixed, 95% CI) Totals not selected
2.3 Mild adverse events 1   Odds Ratio (M‐H, Fixed, 95% CI) Subtotals only
2.3.1 Diarrhoea 1 26 Odds Ratio (M‐H, Fixed, 95% CI) 5.87 [0.25, 135.15]
2.3.2 Halitosis 1 26 Odds Ratio (M‐H, Fixed, 95% CI) 5.87 [0.25, 135.15]
2.3.3 Abdominal pain 1 26 Odds Ratio (M‐H, Fixed, 95% CI) 3.24 [0.12, 87.13]
2.3.4 Dysuria 1 26 Odds Ratio (M‐H, Fixed, 95% CI) 3.24 [0.12, 87.13]
2.3.5 Minor haemoptysis 1 26 Odds Ratio (M‐H, Fixed, 95% CI) 1.00 [0.06, 17.90]